These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8865841)

  • 1. Low dose aspirin and secondary myocardial infarction.
    Lowenthal MN
    Isr J Med Sci; 1996 Sep; 32(9):789-90. PubMed ID: 8865841
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction.
    Bar Dayan Y; Amital H; Levy Y; Shoenfeld Y
    Isr J Med Sci; 1996 May; 32(5):288-91. PubMed ID: 8641865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of acetylsalicylic acid in IHD].
    Lenkovsky F; Neirinck LG; Glezer SV
    Ter Arkh; 1996; 68(8):79-83. PubMed ID: 9019841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acetylsalicylic acid and ACE inhibitors in heart disease--a phenomenon in dogs and cats?].
    Bĕlohlávek J; Aschermann M
    Vnitr Lek; 2002 Aug; 48(8):695-7. PubMed ID: 12425197
    [No Abstract]   [Full Text] [Related]  

  • 5. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478. PubMed ID: 11503323
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy: aspirin.
    Steinhubl SR
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():11B-16B; discussion 16B. PubMed ID: 12724581
    [No Abstract]   [Full Text] [Related]  

  • 7. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.
    Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily aspirin therapy.
    FDA Consum; 2003; 37(5):36. PubMed ID: 14666906
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
    Jolly SS; Pogue J; Haladyn K; Peters RJ; Fox KA; Avezum A; Gersh BJ; Rupprecht HJ; Yusuf S; Mehta SR
    Eur Heart J; 2009 Apr; 30(8):900-7. PubMed ID: 18819961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
    So D; Cook EF; Le May M; Glover C; Williams W; Ha A; Davies R; Froeschl M; Marquis JF; O'Brien E; Labinaz M
    J Invasive Cardiol; 2009 Mar; 21(3):121-7. PubMed ID: 19258643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspirin in secondary cardiovascular prevention: from clinical studies to daily practice].
    Garnier LF
    Ann Cardiol Angeiol (Paris); 1997 Oct; 46(8):507-12. PubMed ID: 9538362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for healthy hearts.
    Ornato J
    Health News; 2001 Jan; 7(1):6. PubMed ID: 11198412
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin: quitting cold turkey could be dangerous. Studies have linked aspirin withdrawal to heart attacks.
    Harv Health Lett; 2005 Oct; 30(12):6. PubMed ID: 16278980
    [No Abstract]   [Full Text] [Related]  

  • 14. [More modest use in secondary prevention, risky in primary prevention].
    MMW Fortschr Med; 2006 Apr; 148(14):10-1. PubMed ID: 16669270
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who should be taking aspirin?
    Harv Heart Lett; 2002 Apr; 12(8):3-5. PubMed ID: 11959516
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin and women--age matters. Aspirin can help healthy women over age 56 prevent both strokes and heart attacks. For younger women, the hazards of aspirin outweigh the benefits.
    Harv Heart Lett; 2005 May; 15(9):1-2. PubMed ID: 15898147
    [No Abstract]   [Full Text] [Related]  

  • 19. Enteric coated aspirin.
    Grossman CM
    Am J Med; 2007 Apr; 120(4):e9. PubMed ID: 17398216
    [No Abstract]   [Full Text] [Related]  

  • 20. Ask the doctor. Almost every day I read how important it is for people with heart disease to take an aspirin. Unfortunately, I am allergic to aspirin. There must be others with the same problem. Are there viable alternatives to aspirin? It's discouraging to realize that I cannot have the benefits available to others.
    Pasternak R
    Harv Heart Lett; 2003 Aug; 13(12):8. PubMed ID: 12936891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.